References
- Hemminki E, Pesonen T, Holme Hansen E. Number and type of psychotopic drugs on the Scandinavian market in 1950–1977. Drug Intell Clin Pharm 1981; 15: 27–37
- Hemminki E, Pesonen T. The function of drug company representatives. Scand J Soc Med 1977; 5: 105–14
- Nordic Statistics on medicines. Nordiska läkemedelsnämnden, Helsinki 1979; 32
- Hemminki E, Bruun K. Läkemedelsbestånd och läkemedelsregistrering i Norden. Nord Med 1980; 95: 310–13
- Biron P. A hopefully biased pilot survey of physician's knowledge of the content of drug combinations. Can Med Assoc J 1973; 109: 35–9
- Gagne J, Biron P, Moisan R. A survey of hospital pharmacists' knowledge of the content of drug combinations. Ann Intern Med 1975; 82: 680–2
- Wehrli A. How to select generic names for drugs. Pharm Internat 1982; 3: 405–8
- Koskikallio I. The pharmaceutical industry. Controlling psychotropic drugs: the Nordic experience, K Bruun. Croon Helm, London 1983; 45–8